BDR Pharma urges regulators to expedite manufacturing, marketing license process for remdesivir Read more
Cipla receives final approval for generic version of Migranal with a Competitive Generic Therapy Designation Read more
Gilead signs Voluntary Licensing Agreements with Cipla, Hetero Labs, Jubilant Lifesciences, Mylan for remdesivir Read more